文献

J-GLOBAL ID：201002258422220313   整理番号：10A0243636

非保護左主幹部冠動脈疾患に対する冠動脈バイパスvs薬剤溶出性ステントの中間結果及び費用

Mid-Term Results and Costs of Coronary Artery Bypass vs Drug-Eluting Stents for Unprotected Left Main Coronary Artery Disease

著者 (9件)： SHIMIZU Tsuyoshi (Dep. of Cardiothoracic Surgery, The Univ. of Tokyo) ,  OHNO Takayuki (Dep. of Cardiovascular Surgery, Mitsui Memorial Hospital) ,  ANDO Jiro (Dep. of Cardiology, The Univ. of Tokyo) ,  FUJITA Hideo (Dep. of Cardiology, The Univ. of Tokyo) ,  NAGAI Ryozo (Dep. of Cardiology, The Univ. of Tokyo) ,  MOTOMURA Noboru (Dep. of Cardiothoracic Surgery, The Univ. of Tokyo) ,  ONO Minoru (Dep. of Cardiothoracic Surgery, The Univ. of Tokyo) ,  KYO Shunei (Dep. of Cardiothoracic Surgery, The Univ. of Tokyo) ,  TAKAMOTO Shinichi (Dep. of Cardiovascular Surgery, Mitsui Memorial Hospital)
資料名： Circulation Journal  (Circulation Journal)
巻： 74  号： 3  ページ： 449-455 (J-STAGE)  発行年： 2010年 
JST資料番号： F0908A  ISSN： 1346-9843  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 背景。薬剤溶出性ステント(DES)時代における非保護左主幹部...

シソーラス用語： *冠動脈疾患 ,...
準シソーラス用語： CABG ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=10A0243636&from=J-GLOBAL&jstjournalNo=F0908A") }}

分類 (1件)： 循環系疾患の治療一般  (GJ05010B)

引用文献 (35件)：

• 1. Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: A meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 2008; 118: 1146-1154.
• 2. Booth J, Clayton T, Pepper J, Nugara F, Flather M, Sigwart U, et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: Six-year follow-up from the Stent or Surgery Trial (SoS). Circulation 2008; 118: 381-388.
• 3. Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: The final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 2005; 46: 575-581.
• 4. Tu JV, Bowen J, Chiu M, Ko DT, Austin PC, He Y, et al. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 2007; 357: 1393-1402.
• 5. Hannan EL, Wu C, Walford G, Culliford AT, Gold JP, Smith CR, et al. Drug-eluting stents vs coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008; 358: 331-341.

タイトルに関連する用語 (5件)： 冠動脈疾患 ,  冠動脈バイパス ,  Vs ,  薬剤溶出性ステント ,  費用